GlucoStabilizer

GlucoStabilizer is an FDA-cleared, clinical glycemic management system designed to help hospitals and healthcare professionals optimize blood glucose control and insulin dosing in inpatient settings. The platform centralizes insulin dosing protocols, real-time glucose data, and automated alerts to support standardized workflows, reduce variability, and improve patient outcomes across critical care, step-down, and medical–surgical units. By replacing manual calculations and disparate tools, GlucoStabilizer enhances clinical efficiency, lowers the risk of hyperglycemia and hypoglycemia, and provides actionable insights that support safe and effective diabetes care. The system integrates seamlessly with electronic medical records and monitoring devices, enabling clinicians to access comprehensive reports, trend analyses, and protocol compliance information that inform therapy decisions. Trusted by multidisciplinary care teams, GlucoStabilizer combines evidence-based algorithms, configurable clinical settings, and robust data visualization to support improved glycemic outcomes and streamlined inpatient diabetes management.

GlucoStabilizer belongs to the Diabetes Management, Insulin Management, Glycemic Management, Glycemic Intelligence Platform category.

GlucoStabilizer is used in industries such as Health, Hospital & Health Care.

GlucoStabilizer is built for Small Business, Mid Size Business

GlucoStabilizer supports English

GlucoStabilizer supports Web-based, Windows devices.

No, GlucoStabilizer does not offer a free trial.

GlucoStabilizer was founded in -3.

GlucoStabilizer has approximately 11-50 employees.

GlucoStabilizer is located in United States.

GlucoStabilizer was founded by GlucoStabilizer.